SCHEMBL4293703

SCHEMBL4293703

Cc1ccnc(NC(=O)COc2ccc(Cl)cc2Cl)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.70
RAB9A P51151 4/20 0.70
HPGD P15428 4/20 0.70
TP53 P04637 2/20 0.70
PKM P14618 2/20 0.70
MITF O75030 1/20 0.70
XBP1 P17861 1/20 0.70
MAPT P10636 7/20 0.66
SMN1; SMN2 Q16637 5/20 0.66
MAPK1 P28482 4/20 0.66
TSHR P16473 2/20 0.66
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
NPSR1 Q6W5P4 3/20 0.57
POLB P06746 1/20 0.57
ALDH1A1 P00352 4/20 0.55
HTT P42858 2/20 0.55
RXFP1 Q9HBX9 1/20 0.55
KCNJ6 P48051 1/20 0.55
KCNJ5 P48544 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2,4-Dichlorophenoxyacetic Acid SCHEMBL18979291 0.86 TDP1 (0.62) NPC1RAB9AHPGDTP53PKM
SCHEMBL4293549 0.85 RAB9A (0.66) NPC1RAB9AHPGDTP53PKM
SCHEMBL4293571 0.84 HPGD (0.69) NPC1RAB9AHPGDTP53PKM
SCHEMBL4298341 0.83 NPC1 (0.67) NPC1RAB9AHPGDTP53PKM
SCHEMBL4302330 0.83 RAB9A (0.64) NPC1RAB9AHPGDTP53PKM
SCHEMBL27374898 0.82 NPC1 (1.00) NPC1RAB9AHPGDTP53PKM
SCHEMBL27374902 0.81 KMT2A (0.71) NPC1RAB9AHPGDTP53PKM
SCHEMBL27374835 0.80 MAPT (0.60) NPC1RAB9AHPGDTP53PKM
SCHEMBL18327156 0.79 MAPT (0.79) NPC1RAB9AHPGDTP53PKM
SCHEMBL27374645 0.79 RAB9A (0.67) NPC1RAB9AHPGDTP53PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090306078-A1 COMPOUNDS THAT INHIBIT HIF-1 ACTIVITY, THE METHOD FOR PREPARATION THEREOF AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM AS AN EFFECTIVE COMPONENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-12-10 US claimed
WO-2008004798-A1 COMPOUNDS THAT INHIBIT HIF-1 ACTIVITY, THE METHOD FOR PREPARATION THEREOF AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM AS AN EFFECTIVE COMPONENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2008-01-10 WO claimed
EP-2943065-B1 AGROCHEMICAL COMPOSITIONS FOR INDUCING ABIOTIC STRESS TOLERANCE VIB VZW (BE) 2017-06-21 EP disclosed
EP-2943065-B1 AGROCHEMICAL COMPOSITIONS FOR INDUCING ABIOTIC STRESS TOLERANCE VIB VZW (BE) 2017-06-21 EP disclosed
US-20160366882-A1 AGROCHEMICAL COMPOSITIONS FOR INDUCING ABIOTIC STRESS TOLERANCE UNIVERSITEIT GENT (BE) 2016-12-22 US disclosed
US-20160366882-A1 AGROCHEMICAL COMPOSITIONS FOR INDUCING ABIOTIC STRESS TOLERANCE UNIVERSITEIT GENT (BE) 2016-12-22 US disclosed
WO-2014090988-A1 AGROCHEMICAL COMPOSITIONS FOR INDUCING ABIOTIC STRESS TOLERANCE VIB VZW (BE) 2014-06-19 WO disclosed
US-8394799-B2 Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2013-03-12 US disclosed
US-8394799-B2 Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2013-03-12 US disclosed
US-8394799-B2 Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2013-03-12 US disclosed
US-20090306078-A1 COMPOUNDS THAT INHIBIT HIF-1 ACTIVITY, THE METHOD FOR PREPARATION THEREOF AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM AS AN EFFECTIVE COMPONENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-12-10 US disclosed
US-20090306078-A1 COMPOUNDS THAT INHIBIT HIF-1 ACTIVITY, THE METHOD FOR PREPARATION THEREOF AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM AS AN EFFECTIVE COMPONENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-12-10 US disclosed
US-20090306078-A1 COMPOUNDS THAT INHIBIT HIF-1 ACTIVITY, THE METHOD FOR PREPARATION THEREOF AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM AS AN EFFECTIVE COMPONENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-12-10 US disclosed
WO-2008004798-A1 COMPOUNDS THAT INHIBIT HIF-1 ACTIVITY, THE METHOD FOR PREPARATION THEREOF AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM AS AN EFFECTIVE COMPONENT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2008-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306078-A1 COMPOUNDS THAT INHIBIT HIF-1 ACTIVITY, THE METHOD FOR PREPARATION THEREOF AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM AS AN EFFECTIVE COMPONENT HIF1AN, HIF1A, VHL NPC1 1221/4885RAB9A 884/4885HPGD 867/4885
US-20160366882-A1 AGROCHEMICAL COMPOSITIONS FOR INDUCING ABIOTIC STRESS TOLERANCE STIP1, GSTO1, GPX4 NPC1 3633/4885RAB9A 1679/4885HPGD 613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.